MG01CI

General Information

Company	Alcobra Ltd.
Description	Extended-release formulation of metadoxine
Molecular Target
Mechanism of Action

Latest Stage of Development	Phase II
Indication	Attention deficit hyperactivity disorder (ADHD)
Partner

Product Details

Archive Items are loading